Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases

 

Show simple item record

dc.contributor.author Salie, M T
dc.contributor.author Yang, Jing
dc.contributor.author Ramírez Medina, Carlos R
dc.contributor.author Zühlke, Liesl J
dc.contributor.author Chishala, Chishala
dc.contributor.author Ntsekhe, Mpiko
dc.contributor.author Gitura, Bernard
dc.contributor.author Ogendo, Stephen
dc.contributor.author Okello, Emmy
dc.contributor.author Lwabi, Peter
dc.contributor.author Musuku, John
dc.contributor.author Mtaja, Agnes
dc.contributor.author Hugo-Hamman, Christopher
dc.contributor.author El-Sayed, Ahmed
dc.contributor.author Damasceno, Albertino
dc.contributor.author Mocumbi, Ana
dc.contributor.author Bode-Thomas, Fidelia
dc.contributor.author Yilgwan, Christopher
dc.contributor.author Amusa, Ganiyu A
dc.contributor.author Nkereuwem, Esin
dc.contributor.author Shaboodien, Gasnat
dc.contributor.author Da Silva, Rachael
dc.contributor.author Lee, Dave C H
dc.contributor.author Frain, Simon
dc.contributor.author Geifman, Nophar
dc.contributor.author Whetton, Anthony D
dc.contributor.author Keavney, Bernard
dc.contributor.author Engel, Mark E
dc.date.accessioned 2022-04-13T11:23:08Z
dc.date.available 2022-04-13T11:23:08Z
dc.date.issued 2022-03-22
dc.identifier.citation Salie, M.T., Yang, J., Ramírez Medina, C.R., Zühlke, L.J., Chishala, C., Ntsekhe, M., Gitura, B. & Ogendo, S. et al. 2022. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. <i>Clinical Proteomics.</i> 19(1):7. http://hdl.handle.net/11427/36373 en_ZA
dc.identifier.uri https://doi.org/10.1186/s12014-022-09345-1
dc.identifier.uri http://hdl.handle.net/11427/36373
dc.description.abstract Background Rheumatic heart disease (RHD) remains a major source of morbidity and mortality in developing countries. A deeper insight into the pathogenetic mechanisms underlying RHD could provide opportunities for drug repurposing, guide recommendations for secondary penicillin prophylaxis, and/or inform development of near-patient diagnostics. Methods We performed quantitative proteomics using Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectrometry (SWATH-MS) to screen protein expression in 215 African patients with severe RHD, and 230 controls. We applied a machine learning (ML) approach to feature selection among the 366 proteins quantifiable in at least 40% of samples, using the Boruta wrapper algorithm. The case–control differences and contribution to Area Under the Receiver Operating Curve (AUC) for each of the 56 proteins identified by the Boruta algorithm were calculated by Logistic Regression adjusted for age, sex and BMI. Biological pathways and functions enriched for proteins were identified using ClueGo pathway analyses. Results Adiponectin, complement component C7 and fibulin-1, a component of heart valve matrix, were significantly higher in cases when compared with controls. Ficolin-3, a protein with calcium-independent lectin activity that activates the complement pathway, was lower in cases than controls. The top six biomarkers from the Boruta analyses conferred an AUC of 0.90 indicating excellent discriminatory capacity between RHD cases and controls. Conclusions These results support the presence of an ongoing inflammatory response in RHD, at a time when severe valve disease has developed, and distant from previous episodes of acute rheumatic fever. This biomarker signature could have potential utility in recognizing different degrees of ongoing inflammation in RHD patients, which may, in turn, be related to prognostic severity. en_US
dc.language.iso en en_US
dc.rights.uri http://creativecommons.org/licenses/by/4.0/ en_US
dc.source Clinical Proteomics en_US
dc.source.uri https://clinicalproteomicsjournal.biomedcentral.com/
dc.subject Rheumatic heart disease en_US
dc.subject Biomarker en_US
dc.subject Inflammatory response en_US
dc.subject Adiponectin en_US
dc.subject Complement component C7 en_US
dc.subject Fibulin-1 en_US
dc.title Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases en_US
dc.type Journal Article en_US
dc.date.updated 2022-03-27T03:10:22Z
dc.language.rfc3066 en
dc.rights.holder The Author(s)
dc.publisher.faculty Faculty of Health Sciences en_US
dc.publisher.department Department of Medicine en_US
dc.source.journalvolume 19 en_US
dc.source.journalissue 1 en_US
dc.source.pagination 7 en_US
dc.identifier.apacitation Salie, M. T., Yang, J., Ramírez Medina, C. R., Zühlke, L. J., Chishala, C., Ntsekhe, M., ... Engel, M. E. (2022). Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. <i>Clinical Proteomics</i>, 19(1), 7. http://hdl.handle.net/11427/36373 en_ZA
dc.identifier.chicagocitation Salie, M T, Jing Yang, Carlos R Ramírez Medina, Liesl J Zühlke, Chishala Chishala, Mpiko Ntsekhe, Bernard Gitura, et al "Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases." <i>Clinical Proteomics</i> 19, 1. (2022): 7. http://hdl.handle.net/11427/36373 en_ZA
dc.identifier.vancouvercitation Salie MT, Yang J, Ramírez Medina CR, Zühlke LJ, Chishala C, Ntsekhe M, et al. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. Clinical Proteomics. 2022;19(1):7. http://hdl.handle.net/11427/36373. en_ZA
dc.identifier.ris TY - Journal Article AU - Salie, M T AU - Yang, Jing AU - Ramírez Medina, Carlos R AU - Zühlke, Liesl J AU - Chishala, Chishala AU - Ntsekhe, Mpiko AU - Gitura, Bernard AU - Ogendo, Stephen AU - Okello, Emmy AU - Lwabi, Peter AU - Musuku, John AU - Mtaja, Agnes AU - Hugo-Hamman, Christopher AU - El-Sayed, Ahmed AU - Damasceno, Albertino AU - Mocumbi, Ana AU - Bode-Thomas, Fidelia AU - Yilgwan, Christopher AU - Amusa, Ganiyu A AU - Nkereuwem, Esin AU - Shaboodien, Gasnat AU - Da Silva, Rachael AU - Lee, Dave C H AU - Frain, Simon AU - Geifman, Nophar AU - Whetton, Anthony D AU - Keavney, Bernard AU - Engel, Mark E AB - Background Rheumatic heart disease (RHD) remains a major source of morbidity and mortality in developing countries. A deeper insight into the pathogenetic mechanisms underlying RHD could provide opportunities for drug repurposing, guide recommendations for secondary penicillin prophylaxis, and/or inform development of near-patient diagnostics. Methods We performed quantitative proteomics using Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectrometry (SWATH-MS) to screen protein expression in 215 African patients with severe RHD, and 230 controls. We applied a machine learning (ML) approach to feature selection among the 366 proteins quantifiable in at least 40% of samples, using the Boruta wrapper algorithm. The case–control differences and contribution to Area Under the Receiver Operating Curve (AUC) for each of the 56 proteins identified by the Boruta algorithm were calculated by Logistic Regression adjusted for age, sex and BMI. Biological pathways and functions enriched for proteins were identified using ClueGo pathway analyses. Results Adiponectin, complement component C7 and fibulin-1, a component of heart valve matrix, were significantly higher in cases when compared with controls. Ficolin-3, a protein with calcium-independent lectin activity that activates the complement pathway, was lower in cases than controls. The top six biomarkers from the Boruta analyses conferred an AUC of 0.90 indicating excellent discriminatory capacity between RHD cases and controls. Conclusions These results support the presence of an ongoing inflammatory response in RHD, at a time when severe valve disease has developed, and distant from previous episodes of acute rheumatic fever. This biomarker signature could have potential utility in recognizing different degrees of ongoing inflammation in RHD patients, which may, in turn, be related to prognostic severity. DA - 2022-03-22 DB - OpenUCT DP - University of Cape Town IS - 1 J1 - Clinical Proteomics KW - Rheumatic heart disease KW - Biomarker KW - Inflammatory response KW - Adiponectin KW - Complement component C7 KW - Fibulin-1 LK - https://open.uct.ac.za PY - 2022 T1 - Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases TI - Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases UR - http://hdl.handle.net/11427/36373 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/ Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/